Integer Holdings Corporation (ITGR) Stock Analysis
Momentum Cont setup
Healthcare · Medical Devices
Hold if already holding. Not a fresh buy at $88.16, but acceptable to hold if already in. Reasons: Concentration risk — Customer: Abbott Laboratories, Boston Scientific and Medtronic (49.0%); Analyst target reached - limited upside remaining.
Integer Holdings is a medical device CDMO manufacturing components and finished devices for Cardio & Vascular, Cardiac Rhythm Management, and Neuromodulation OEM customers from facilities in the U.S., Mexico, Ireland, and other countries. Top 3 customers (Abbott Laboratories,... Read more
Hold if already holding. Not a fresh buy at $88.16, but acceptable to hold if already in. Reasons: Concentration risk — Customer: Abbott Laboratories, Boston Scientific and Medtronic (49.0%); Analyst target reached - limited upside remaining. Chart setup: Trend continuation, RSI 56, MACD bullish. Multiple concerning factors. Consider reducing position. | News modifier +2 (SELL_IF_HOLDING → HOLD_IF_HOLDING) Score 4.8/10, moderate confidence.
Passes 7/9 gates (positive momentum, clean insider activity, no SEC red flags, news boost analyst cluster(6), earnings proximity 74d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
Recent Developments — Integer Holdings Corporation
Latest news
- Here's why you should retain Integer Holdings stock in your portfolio - MSN — MSN positive
- What To Expect From Integer Holdings’s (ITGR) Q1 Earnings - Yahoo Finance — Yahoo Finance neutral
- What To Expect From Integer Holdings’s (ITGR) Q1 Earnings - StockStory — StockStory neutral
- What To Expect From Integer Holdings’s (ITGR) Q1 Earnings - MSN — MSN neutral
- What To Expect From Integer Holdings’s (ITGR) Q1 Earnings - FinancialContent — FinancialContent neutral
Generated 2026-05-20T20:21:21Z.
Thesis
Key Metrics
Quality Signals
Concentration Risks(10-K Item 1A)
- HIGHCustomerAbbott Laboratories, Boston Scientific and Medtronic49%10-K Item 1: 'During 2025, three of our customers, Abbott Laboratories, Boston Scientific and Medtronic were each in excess of 10% of total sales and collectively accounted for 49% of our total sales.'
Material Events(8-K, last 90d)
- 2026-03-12Item 5.02LOWPer Cooperation Agreement with Irenic Capital dated March 9, 2026, James F. Flanagan and Irenic-designated Aaron Kapito appointed to Board. Two incumbent directors will not stand for re-election at 2026 Annual Meeting.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
3 floor-breakers
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $88.16, but acceptable to hold if already in. Reasons: Concentration risk — Customer: Abbott Laboratories, Boston Scientific and Medtronic (49.0%); Analyst target reached - limited upside remaining. Chart setup: Trend continuation, RSI 56, MACD bullish. Multiple concerning factors. Consider reducing position. | News modifier +2 (SELL_IF_HOLDING → HOLD_IF_HOLDING) Target $89.48 (+1.5%), stop $81.99 (−7.5%), A.R:R -0.3:1. Score 4.8/10, moderate confidence.
Take-profit target: $89.48 (+1.5% upside). Target $89.48 (+1.5%), stop $81.99 (−7.5%), A.R:R -0.3:1. Stop-loss: $81.99.
Concentration risk — Customer: Abbott Laboratories, Boston Scientific and Medtronic (49.0%); Analyst target reached - limited upside remaining; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.4).
Integer Holdings Corporation trades at a P/E of 21.9 (forward 13.0). TrendMatrix value score: 6.3/10. Verdict: Hold.
17 analysts cover ITGR with a consensus score of 3.7/5. Average price target: $97.
What does Integer Holdings Corporation do?Integer Holdings is a medical device CDMO manufacturing components and finished devices for Cardio & Vascular, Cardiac...
Integer Holdings is a medical device CDMO manufacturing components and finished devices for Cardio & Vascular, Cardiac Rhythm Management, and Neuromodulation OEM customers from facilities in the U.S., Mexico, Ireland, and other countries. Top 3 customers (Abbott Laboratories, Boston Scientific, Medtronic) collectively represented 49% of 2025 revenues.